pristane诱导小鼠狼疮模型的建立及其免疫细胞功能变化的研究

《pristane诱导小鼠狼疮模型的建立及其免疫细胞功能变化的研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、硕士学位论文Pristane诱导小鼠狼疮模型的建立及其免论文题目：疫细胞功能变化的研究Constructionofpristane-inducedmurinelupusmodelandresearchonthechangesofitsimmunecellfunction研究生姓名:吴正中指导教师:吴俊英教授学科专业:临床检验诊断学研究方向:分子免疫诊断论文工作时间:2011年8月至2013年4月2013年4月10日学位论文原创性声明本人郑重声明：本人所呈交的学位论文是本人在导师指导下独立进行实验研究工作所取得的成果，本论文中

2、不包含其他人已经发表或已经获取得的研究成果。在本论文撰写中所引用其他研究者的研究内容和成果时已在论文中给予特别标注和明确说明。对本论文的研究过程中给予帮助的其他人士，以及论文撰写中所提供的建议等的贡献也已作了致谢说明。本人完全理解本声明的法律责任，以及所涉及的结果将由本人承担。学位论文作者签名：日期：年月日关于学位论文著作权共享声明根据《中华人民共和国著作权法》和《高等院校知识产权管理条例》，本学位论文题目：Pristane诱导小鼠狼疮模型的建立及共刺激信号与其发病关系的研究，是研究生在导师指导下完成的职务作品，得到学校相关

3、部门科室的物质技术和经费支持，因此，本学位论文的著作权由研究生，导师和学校共同享有，均享有署名权和使用权等权益；本学位论文成果归属学校。根据国家学位授予条例，学校对本学位论文有使用权，包括保存本学位论文；因教学和科研的目的，保留在图书馆被查阅或借阅；学校可根据国家规定将本学位论文送交国家有关部门保留和使用。学校在公布本学位论文的全部或部分内容时，应保障研究生和导师的署名权等权益。研究生和导师在公开发表本学位论文的全部或部分内容时必须保障学校的署名权等权益，即在发表论文时学校及相关部门科室应署名为作者单位。声明人完全理解本声明

4、的法律责任。研究生签名：导师签名：日期：年月日目录一、中文摘要····················································································1二、英文摘要····················································································3三、论文正文1、前言················································

5、···········································62、材料与仪器··················································································93、实验方法····················································································114、结果···································

6、······················································215、讨论·························································································41四、结论························································································45五、参考文献··············

7、····································································46六、致谢························································································52七、附录A、系统性红斑狼疮诊断标准······························································53B、英文缩略词表············

8、·································································54C、常用试剂配制······································································